Trial Profile
A phase I trial evaluating pharmacodynamics of deforolimus (AP23573, MK-8669) delivered orally on multiple dosing schedules
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 11 Nov 2008
Price :
$35
*
At a glance
- Drugs Ridaforolimus (Primary)
- Indications Solid tumours
- Focus Pharmacodynamics
- Sponsors ARIAD Pharmaceuticals
- 11 Nov 2008 New trial record.